In sarcoma and prostatic adenocarcinoma, CAFs secrete TGF-β, IL-6 and tumor necrosis factor-alpha (TNF-α) that activate YAP1/TAZ and NFκB signaling in tumor cells, resulting in inhibition of tumor cell proliferation [128,129,130,131]. This evidence concerns the gene TNF and prostate adenocarcinoma.